12 July 2024
12 July 2024
This acquisition strengthens AA Medical's position as a comprehensive third-party alternative provider of medical supplies.
The medical technology giant is flexing its muscles in the world of sports sponsorship.
Illumina has seen a sharp rise in stock price after acquiring the single-cell analysis company in a bid to expand its RNA sequencing operations.
This clearance is based on the results of the FUSE IDE study that enrolled 227 patients across 18 US sites.
The INSPIRA ART100 is an extra-corporeal membrane oxygenation and cardiopulmonary bypass system.
The company plans to initiate a clinical trial in Australia for its six-month GLP-1 implant in obese or overweight patients in Q4 this year.
Ireland is the first country to gain access to this diagnostic tool, which rapidly assesses coagulation status at the patient's bedside.
Medi-Cal’s new policy will cover more patients with MDD who do not respond adequately to antidepressants.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
